Abstract
The term “Ischemic preconditioning” is used to describe the phenomenon of protection of the myocardium from ischemic-reperfusion injury by preceding short sublethal ischemic episodes. Ischemic preconditioning is one of the most powerful means known to protect the myocardium during subsequent ischemic-reperfusion insult. However, its mechanisms are still unknown. Understanding its mechanisms and development of “preconditioning-mimetic ”drugs may allow myocardial protection in various clinical situations in which the heart is exposed to ischemia. In the following chapter we shall discuss human myocardial preconditioning by brief ischemic episodes in four major clinical situations:
-
1.
Cardiopulmonary bypass: ischemic preconditioning as an alternative method to cardioplegia for the preservation of the myocardium.
-
2.
Percutaneous transluminal coronary angioplasty: changes in severity of pain and electrocardiographic manifestations of ischemia during repeated balloon occlusion.
-
3.
Acute myocardial infarction: the effects of previousanginaon infarct size, left ventricular function, ventricular arrhythmias, and prognosis.
-
4.
Adaptation to angina: augmentation of maximal effort during repeated exertion.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Przyklenk K, Kloner RA. Preconditioning: a balanced perspective. Br Heart J 1995;74:575–577.
Lawson CS, Downey JM. Preconditioning: State of the art myocardial protection. Cardiovasc Res 1993;27:542–550.
Andreotti F, Pasceri V, Hackett DR. et al. Pereinfarction angina as a predictor of more rapid coronary thrombolysis in patients with acute myocardial infarction. N Engl J Med 1996;334:7–12.
Kloner RA, Yellon D. Does ischemic preconditioning occur in patients? J Am Coll Cardiol 1994; 24:1133–1142.
Yellon DM, Alkhulaif AM, Pugsley WB. Preconditioning the human myocardium. Lancet 1993;342:276–277.
Abd-Elfattah AS, Wechsler AS. Myocardial preconditioning: a model or a phenomenon? J Card Surg 1995;10:381–388.
Tomai F, Crea F, Gaspardone A et al. Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide, a selective ATP-sensitive K+ channel blocker. Circulation 1994;90:700–705.
Braunwald E. Acute myocardial infarction-the value of being prepared. N Engl J Med 1996;334:51–52.
Tomai F, Crea F, Gaspardone A, et al. Determinants of myocardial ischemia during percutaneous transluminal coronary angioplasty in patients with significant narrowing of a single coronary artery and stable or unstable angina pectoris. Am J Cardiol 1994;74:1089–1094.
Iwasaka T, Nakamura S, Karakawa M et al. Cardioprotective effect of unstable angina prior to acute anterior myocardial infarction. Chest 1994;105:57–61.
Anzai T, Yoshikawa T, Asakura Y et al. Preinfarction angina as a major predictor of left ventricular function and long-term prognosis after a first Q wave myocardial infarction. J Am Coll Cardiol 1995;26:319–327.
Kloner RA, Shook T, Przyklenk K et al. Previous angina alters in-hospital outcome in TIMI 4. A clinical correlate to preconditioning? Circulation 1995;91:37–47.
Nakagawa Y, Ito H, Kitakaze M et al. Effect of angina pectoris on myocardial protection in patients with reperfused anterior wall myocardial infarction: retrospective clinical evidence of “preconditioning”. J Am Coll Cardiol 1995;25:1076–1083.
Haider AW, Andreotti F, Hackett DR et al. Early spontaneous intermittent myocardial reperfusion during acute myocardial infarction is associated with augmented thrombogenic activity and less myocardial damage. J Am Coll Cardiol 1995;26:662–667.
Maybaum S, Han M, Mogilevsky J et al. Repeated exercise induced ischemia causes myocardial preconditioning (abstract). J Am Coll Cardiol 1995;25:22A.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1997 Springer Science+Business Media New York
About this chapter
Cite this chapter
Birnbaum, Y., Kloner, R.A. (1997). Clinical Applications of Ischemic Preconditioning. In: Mentzer, R.M., Kitakaze, M., Downey, J.M., Hori, M. (eds) Adenosine, Cardioprotection and Its Clinical Application. Developments in Cardiovascular Medicine, vol 194. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8736-5_15
Download citation
DOI: https://doi.org/10.1007/978-1-4419-8736-5_15
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-4676-0
Online ISBN: 978-1-4419-8736-5
eBook Packages: Springer Book Archive